Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;32(2):573-583.
doi: 10.1007/s40199-024-00527-w. Epub 2024 Jul 4.

Preparation of poly(vinyl alcohol) nanofibers containing disulfiram-copper complex by electrospinning: a potential delivery system against melanoma

Affiliations

Preparation of poly(vinyl alcohol) nanofibers containing disulfiram-copper complex by electrospinning: a potential delivery system against melanoma

Gomaa F El Fawal et al. Daru. 2024 Dec.

Abstract

Background: Melanoma poses a significant threat to human health, making the development of a safe and effective treatment a crucial challenge. Disulfiram (DS) is a proven anticancer drug that has shown effectiveness when used in combination with copper (DS-Cu complex).

Objectives: This study focuses on encapsulation of DS-copper complex into nanofiber scaffold from polyvinyl alcohol (PVA) (DS-Cu@PVA). In order to increase bioavailability towards melanoma cell lines and decrease its toxicity.

Methods: The scaffold was fabricated through an electrospinning process using an aqueous solution, and subsequently analyzed using ART-Fourier transform infrared spectroscopy (ART-FTIR), scanning electron microscopy (SEM), and energy dispersive X-ray analysis (EDX). Additionally, cellular cytotoxicity, flow cytometry analysis, and determination of caspase 3 activity were conducted to further characterize the scaffold.

Results: The results confirmed that encapsulation of DS-Cu complex into PVA was successful via different characterization. The scanning electron microscopy (SEM) analysis revealed that the diameter of the nanofibers remained consistent despite the addition of DS-Cu. Additionally, ATR-FTIR confirmed that the incorporation of DS-Cu into PVA did not significantly alter the characteristic peaks of PVA. Furthermore, the cytotoxicity assessment of the DS-Cu@PVA nanofibrous scaffold using human normal skin cells (HFB4) demonstrated its superior biocompatibility compared to DS-Cu-free counterparts. Notably, the presence of DS-Cu maintained its effectiveness in promoting apoptosis by increasing cellular reactive oxygen species, proapoptotic gene expression, and caspase 3 activity, while simultaneously reducing glutathione levels and oncogene expression in human and mouse melanoma cell lines (A375 and B16F10, respectively). Overall, these findings suggest that the addition of DS-Cu to PVA nanofibers enhances their biocompatibility and cytotoxic effects on melanoma cells, making them a promising candidate for biomedical applications.

Conclusion: The findings indicate that the targeted delivery of DS-Cu onto a PVA nanofiber scaffold holds potential approach to enhance the efficacy of DS-Cu in combating melanoma.

Keywords: Anticancer; Disulfiram; Electrospinning; Melanoma; Polyvinyl alcohol.

PubMed Disclaimer

Conflict of interest statement

Declarations Competing interests The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Morphology of electrospun PVA and DS-Cu@PVA nanofiber mixed nanofibers, nanofiber distribution (a-e), Edx analysis (f). [PVA (13%) in ethanol: distilled water (1:1) and DS-Cu @PVA ((b) 1 µM, c 2 µM, d 4 µM, and (e) 6 µM)]
Fig. 2
Fig. 2
FTIR spectra for electrospun DS-Cu@PVA nanofiber scaffolds (a) PVA; b DS-Cu; c DS-Cu@PVA (2 µm); and (d) DS-Cu@PVA (6 µm). [PVA (13%) in ethanol: distilled water (1:1) and DS-Cu@PVA ((c) 2 µM, d 6 µM)]
Fig. 3
Fig. 3
Cytotoxicity of DS-Cu-free and DS-Cu@PVA nanofibers scaffolds against normal dermal cells and melanoma cell lines. A Cytotoxicity of serial concentrations of DS-Cu-free and DS-Cu@PVA nanofibers scaffolds on human normal dermal fibroblast (HFB4) cells. B, C Cytotoxicity of serial concentrations of DS-Cu-free and DS-Cu@PVA nanofibers scaffolds against human and murine melanoma cell lines (A375 and H16-F10, respectively). D Morphological alterations of normal dermal cells and both melanoma cell lines after 72 h treatment with 2 μM of DS-Cu-free and DS-Cu@PVA nanofibers scaffolds using phase contrast microscope (Magnification × 100). Data are demonstrated as mean ± SEM. [PVA (13%) in ethanol: distilled water (1:1) and DS-Cu@PVA (1 μM, 2 μM, 4 μM, and 6 μM)]
Fig. 4
Fig. 4
Flow cytometric analysis of apoptosis induction in DS-Cu-free and DS-Cu@PVA-treated melanoma cells at 2 μM. Flow cytometry illustration for apoptotic activity, including (I) flow charts of the untreated, DS-Cu-free and DS-Cu@PVA-treated human A375 cells after staining with annexin V/PI and (II) percentages of total apoptotic cell populations in the untreated and treated A375. Data are expressed as mean ± SEM. [PVA (13%) in ethanol: distilled water (1:1) and DS-Cu@PVA (2 μM)]
Fig. 5
Fig. 5
Relative fold change in cellular reactive oxygen species (ROS) and glutathione (GSH) in DS-Cu-free and DS-Cu@PVA-treated melanoma cells at 2 μM. A Relative fold increment in ROS content and (B) relative fold decrement in GSH in the treated human and murine melanoma cell lines (A375 and H16-F10, respectively). Data are expressed as mean ± SEM. [PVA (13%) in ethanol: distilled water (1:1) and DS-Cu@PVA (2 μM)]
Fig. 6
Fig. 6
QPCR detection of key gene expressions and caspase activity in DS-Cu-free and DS-Cu@PVA-treated melanoma cells. A Relative fold change in the expression of p53, p21, β-catenin, BCL-2, and cyclin D after 72 h incubation of A375 cells with DS-Cu-free and DS-Cu@PVA at 2 μM. B Relative fold increment in caspase 3 activity in the treated human and mouse melanoma cells (A375 and H16-F10, respectively) relative to the untreated cells. Data are expressed as mean ± SEM. [PVA (13%) in ethanol: distilled water (1:1) and DS-Cu@PVA (2 μM)]

Similar articles

Cited by

References

    1. Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. - PubMed
    1. Robert S, et al. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis. Lancet Oncol. 2024;4:509–17. - PubMed
    1. Jiaran Z, Huichun T, Lili M, Lu S. Treatment of acral and mucosal melanoma: current and emerging targeted therapies. Crit Rev Oncol Hematol. 2024;193:104221. - PubMed
    1. Ruilong W, Qin Y, Xiao L, Jinfeng W. Unraveling lipid metabolism reprogramming for overcoming drug resistance in melanoma. Biochem Pharmacol. 2024;223:116122. - PubMed
    1. Cen D, et al. Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Mol Cancer Ther. 2002;1:197–204. - PubMed